Evolving Myeloma Treatment Options | CAR T-Cell Therapy
https://vimeo.com/930271830 What is CAR T-cell therapy, and who is it right for? Dr. Omar Nadeem of Dana-Farber Cancer Institute discusses the role of this therapy in myeloma care and shares…
Clinical Trials for Myeloma Treatment | Essential Information for Patients
https://vimeo.com/930271725 How do clinical trials advance treatment options for myeloma? Dr. Omar Nadeem discusses the important role of clinical trials in improving patient care, key questions to ask your care…
Myeloma Patient Expert Q&A: Dr. Ola Landgren
https://vimeo.com/929981922 START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team. In this webinar, Dr. Ola Landgren…
Dr. Sikander Ailawadhi: Why Is It Important for You to Empower Patients?
Dr. Sikander Ailawadhi: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. How can healthcare providers empower patients? Expert Dr. Sikander Ailawadhi from the…
Considering a Myelofibrosis Clinical Trial? Questions You Should Ask
https://vimeo.com/928809660 What questions should patients ask when considering a myelofibrosis clinical trial? Expert Dr. Gabriela Hobbs discusses how clinical trials may fit into a treatment plan and shares key questions…
What Are the Currently Approved Myelofibrosis Therapies?
https://vimeo.com/928808656 Expert Dr. Gabriela Hobbs shares an overview of available therapies and important considerations when choosing a myelofibrosis treatment plan. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the…
Myelofibrosis Clinical Trial Participation | How Does It Move Research Forward?
https://vimeo.com/928808368 How do clinical trials move myelofibrosis research forward? Expert Dr. Gabriela Hobbs discusses the purpose of clinical trials, factors that may impact participation, and how trials can benefit patients….
Which Emerging Myelofibrosis Therapies Are Showing Promise?
https://vimeo.com/928806986 What are the latest advances in myelofibrosis therapy? Expert Dr. Gabriela Hobbs discusses various inhibitor therapies, including BET inhibitors, that are currently being studied in clinical trials for patients…
Primary vs Secondary Myelofibrosis | What’s the Difference?
https://vimeo.com/928806744 How are primary myelofibrosis and secondary myelofibrosis defined? Expert Dr. Gabriela Hobbs explains the differences between the conditions and discusses a common scenario that secondary myelofibrosis patients often experience. …
Head & Neck Cancer: What Do You Need to Know About Evolving Treatment and Research?
https://vimeo.com/928134822 Head and neck cancer research is evolving rapidly, leading to expanded treatment options for patients. Expert and researcher Dr. Ezra Cohen discusses key factors that impact head and neck…
Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care
https://vimeo.com/928072269 With the quickly evolving landscape of myeloma treatment and care, it’s important to work with your healthcare team to determine a care plan. In this program, Dr. Omar Nadeem…
Expert Advice for Patients With Small Cell Lung Cancer
https://vimeo.com/927722732 Dr. Triparna Sen, a leading small cell lung cancer (SCLC) researcher and expert, shares key advice for patients. Dr. Sen stresses the importance of working closely with your doctor,…